Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin W. Quinlan currently holds 45,486 shares of ANIKA THERAPEUTICS INC (ANIK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin W. Quinlan has been a net seller of ANIK stock. They have purchased $57.0K and sold $843.0K worth of shares.
Kevin W. Quinlan's most recent insider trade was on Mar 27, 2013, when they sold 18,374 shares at $11.24 per share.
Kevin W. Quinlan serves as Executive at ANIKA THERAPEUTICS INC (ANIK). They have executed 20 insider transactions totaling $900.0K over their tenure at the company.
Kevin W. Quinlan holds the position of Executive at ANIKA THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Kevin W. Quinlan has shown a selling trading pattern, with $57.0K in total purchases and $843.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin W. Quinlan was on Mar 21, 2013, when they purchased $281.0K worth of ANIK shares. This transaction involved 25,000 shares at $11.24 per share.
Kevin W. Quinlan currently owns 45,486 shares of ANIKA THERAPEUTICS INC (ANIK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin W. Quinlan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin W. Quinlan has 20 Form 4 filings on record as an insider at ANIKA THERAPEUTICS INC.
Set alerts for Kevin W. Quinlan and 40,000+ other insiders.